Brent Pfeiffenberger

Outlook Microsoft Office 365 Amazon CloudFront Amazon Elastic Load Balancer Amazon AWS New Relic Mobile Friendly Google Maps Google Maps (Non Paid Users) Google Tag Manager WordPress.org Viewpoint Circle Remote

cell therapy oncology ipsc allogeneic biotechnology: biological products (no diagnostic substances) health care car-t therapy nk cells t cells allogeneic therapy gene editing precision medicine induced pluripotent stem cells cell therapy platform autoimmune diseases cancer treatment immunotherapy clinical trials cell manufacturing therapeutic applications tumor targeting host immune evasion safety switch bulk manufacturing precision gene editing therapeutic breakthroughs off-the-shelf therapies allogeneic ipsc targeted therapies immune system evasion chimeric antigen receptor stem cell biology adaptive t cells cell-derived therapies hematologic malignancies solid tumors anti-drug antibodies manufacturing efficiency therapeutic response clinical efficacy immune cell therapies engineering safety profiles pro-survival signals dose escalation common engineered progenitors il15 secretion biotechnology innovations hemapoiesis cancer-fighting cells patient access precision cell therapy therapeutic landscape allogeneic cell therapies ipsc-derived therapies natural killer cells t cell therapies protein engineering scalable manufacturing preclinical candidates clinical-stage candidates cnty-101 cnty-102 cnty-104 cnty-106 cnty-107 immune evasion innovative treatments therapeutic efficacy proprietary technologies collaborations immuno-oncology systemic lupus erythematosus lupus nephritis b-cell malignancies acute myeloid leukemia multiple myeloma fireside chat pipeline development financial stability strategic initiatives hospital & health care health wellness & fitness